Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

DSpace Repository

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

Author: Seymour, John F.; Marcus, Robert; Davies, Andrew; Gallop-Evans, Eve; Grigg, Andrew; Haynes, Andrew; Herold, Michael; Illmer, Thomas; Nilsson-Ehle, Herman; Soekler, Martin; Duenzinger, Ulrich; Nielsen, Tina; Launonen, Aino; Hiddemann, Wolfgang
Tübinger Autor(en):
Sökler, Martin
Published in: Haematologica (2019), Bd. 104, H. 6, S. 1202-1208
Verlagsangabe: Ferrata Storti Foundation
Language: English
Full text: http://dx.doi.org/10.3324/haematol.2018.209015
ISSN: 0390-6078
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)